1
NR 566 Final Exam Advanced Pharmacology for
Care of the Family Actual Exam 2026/2027 –
Complete Exam-Style Questions with Detailed
Rationales | Pass Guaranteed – A+ Graded
[SECTION 1: Pharmacokinetics & Pharmacodynamics — Questions 1-12]
Q1: A 65-year-old patient with hypertension and heart failure is prescribed digoxin. The nurse
practitioner knows that digoxin has a narrow therapeutic index. What is the current guideline-
recommended therapeutic range for serum digoxin levels in the treatment of heart failure?
A. 0.8 to 2.0 ng/mL
B. 1.0 to 2.5 ng/mL
C. 0.5 to 1.0 ng/mL
D. 0.5 to 0.8 ng/mL [CORRECT]
Correct Answer: D
Rationale: Current clinical practice guidelines recommend a lower therapeutic range of 0.5 to 0.8
ng/mL for heart failure to minimize the risk of toxicity (such as arrhythmias and visual changes)
while maintaining efficacy. Older ranges (up to 2.0 ng/mL) were associated with increased
mortality. Levels for arrhythmia control may be slightly higher, but for heart failure, the lower
range is the standard of care.
Q2: A patient taking phenytoin (Dilantin) for seizure control presents with nystagmus, ataxia,
and confusion. The nurse practitioner suspects toxicity. Phenytoin exhibits zero-order kinetics at
therapeutic doses. What does this imply regarding drug metabolism?
A. A constant percentage of drug is eliminated per unit of time.
B. A constant amount of drug is eliminated per unit of time, regardless of plasma concentration.
[CORRECT]
C. The drug follows first-order kinetics exclusively at all doses.
D. The rate of elimination is directly proportional to the square of the plasma concentration.
,2
Correct Answer: B
Rationale: Phenytoin follows Michaelis-Menten (saturable) kinetics. At therapeutic
concentrations, the hepatic enzymes responsible for metabolism become saturated. Consequently,
the drug exhibits zero-order pharmacokinetics where a constant amount (not percentage) of drug
is metabolized per unit of time. Small increases in dose can lead to disproportionate, exponential
increases in plasma concentration, rapidly leading to toxicity.
Q3: A nurse practitioner is prescribing a medication metabolized by CYP3A4. The patient
reports drinking grapefruit juice daily. What is the expected effect on the medication's
pharmacokinetics?
A. Induction of CYP3A4, leading to decreased drug levels and potential therapeutic failure.
B. Inhibition of CYP3A4, leading to increased drug levels and potential toxicity. [CORRECT]
C. No effect, as grapefruit juice primarily affects CYP2D6.
D. Increased renal excretion of the drug, decreasing its half-life.
Correct Answer: B
Rationale: Grapefruit juice contains furanocoumarins, which irreversibly inhibit intestinal
CYP3A4 enzymes. This inhibition reduces the first-pass metabolism of drugs that are CYP3A4
substrates, leading to increased bioavailability and higher plasma levels of the drug. This can
result in toxicity. St. John's Wort, conversely, is a potent inducer.
Q4: Which of the following patients is most likely to experience an exaggerated response to a
standard dose of a highly protein-bound drug (e.g., warfarin)?
A. A 30-year-old athlete with high albumin levels.
B. An elderly patient with malnutrition and hypoalbuminemia. [CORRECT]
C. A pediatric patient with normal liver function.
D. A pregnant patient in the second trimester.
Correct Answer: B
Rationale: Drugs that are highly protein-bound (like warfarin) circulate mostly bound to
albumin; only the free (unbound) fraction is pharmacologically active. Hypoalbuminemia,
,3
common in elderly and malnourished patients, decreases the number of binding sites. This results
in a higher free fraction of the drug, potentially leading to toxicity even at standard doses.
Q5: A patient with a history of end-stage renal disease requires antibiotic therapy. The nurse
practitioner prescribes a drug eliminated primarily by the kidneys. What adjustment is necessary?
A. Increase the dose frequency to ensure adequate tissue penetration.
B. Extend the dosing interval or reduce the dose. [CORRECT]
C. Administer the drug intravenously only to bypass first-pass metabolism.
D. No adjustment is needed as long as liver function is normal.
Correct Answer: B
Rationale: Renal impairment reduces the clearance of drugs eliminated via the kidneys (e.g.,
aminoglycosides, penicillins, vancomycin). To prevent drug accumulation and toxicity, the
dosing interval should be extended (giving the drug less frequently) or the dose reduced.
Increasing the dose (A) would worsen accumulation.
Q6: The nurse practitioner is educating a patient about the "first-pass effect." Which route of
administration is subject to the highest degree of first-pass metabolism?
A. Oral [CORRECT]
B. Sublingual
C. Intravenous
D. Transdermal
Correct Answer: A
Rationale: First-pass metabolism refers to the partial inactivation of a drug by the liver before it
reaches systemic circulation. Oral administration is the route most significantly affected because
the drug is absorbed from the GI tract and travels directly to the liver via the portal vein. IV (C)
bypasses this entirely.
, 4
Q7: A drug is described as a "partial agonist" at the mu-opioid receptor. How does this differ
from a "full agonist"?
A. It produces a maximal response regardless of receptor occupancy.
B. It produces a submaximal response even when all receptors are occupied. [CORRECT]
C. It binds to the receptor but produces no effect, blocking full agonists.
D. It has a lower affinity for the receptor than a full agonist.
Correct Answer: B
Rationale: A partial agonist binds to the receptor and activates it but produces a submaximal
response (lower Emax) compared to a full agonist, even when all receptors are occupied. This
property can be useful for stabilizing a receptor system (e.g., buprenorphine in opioid use
disorder). Option C describes an antagonist.
Q8: The nurse practitioner is reviewing the concept of "Volume of Distribution" (Vd). A drug
with a high Vd (e.g., digoxin or lipophilic drugs) is likely to:
A. Remain primarily in the blood plasma.
B. Distribute widely into tissues and body fat. [CORRECT]
C. Be easily removed by dialysis.
D. Have a short half-life.
Correct Answer: B
Rationale: A high volume of distribution indicates that the drug preferentially distributes out of
the plasma and into the tissues (e.g., adipose tissue, intracellular). These drugs are often
lipophilic. They are often difficult to remove via dialysis (C) because they are not floating freely
in the blood. Drugs with high Vd typically have long half-lives.
Q9: Which medication requires a "washout period" of 5 weeks before starting an SSRI to prevent
Serotonin Syndrome?
A. Moclobemide
B. Tranylcypromine
NR 566 Final Exam Advanced Pharmacology for
Care of the Family Actual Exam 2026/2027 –
Complete Exam-Style Questions with Detailed
Rationales | Pass Guaranteed – A+ Graded
[SECTION 1: Pharmacokinetics & Pharmacodynamics — Questions 1-12]
Q1: A 65-year-old patient with hypertension and heart failure is prescribed digoxin. The nurse
practitioner knows that digoxin has a narrow therapeutic index. What is the current guideline-
recommended therapeutic range for serum digoxin levels in the treatment of heart failure?
A. 0.8 to 2.0 ng/mL
B. 1.0 to 2.5 ng/mL
C. 0.5 to 1.0 ng/mL
D. 0.5 to 0.8 ng/mL [CORRECT]
Correct Answer: D
Rationale: Current clinical practice guidelines recommend a lower therapeutic range of 0.5 to 0.8
ng/mL for heart failure to minimize the risk of toxicity (such as arrhythmias and visual changes)
while maintaining efficacy. Older ranges (up to 2.0 ng/mL) were associated with increased
mortality. Levels for arrhythmia control may be slightly higher, but for heart failure, the lower
range is the standard of care.
Q2: A patient taking phenytoin (Dilantin) for seizure control presents with nystagmus, ataxia,
and confusion. The nurse practitioner suspects toxicity. Phenytoin exhibits zero-order kinetics at
therapeutic doses. What does this imply regarding drug metabolism?
A. A constant percentage of drug is eliminated per unit of time.
B. A constant amount of drug is eliminated per unit of time, regardless of plasma concentration.
[CORRECT]
C. The drug follows first-order kinetics exclusively at all doses.
D. The rate of elimination is directly proportional to the square of the plasma concentration.
,2
Correct Answer: B
Rationale: Phenytoin follows Michaelis-Menten (saturable) kinetics. At therapeutic
concentrations, the hepatic enzymes responsible for metabolism become saturated. Consequently,
the drug exhibits zero-order pharmacokinetics where a constant amount (not percentage) of drug
is metabolized per unit of time. Small increases in dose can lead to disproportionate, exponential
increases in plasma concentration, rapidly leading to toxicity.
Q3: A nurse practitioner is prescribing a medication metabolized by CYP3A4. The patient
reports drinking grapefruit juice daily. What is the expected effect on the medication's
pharmacokinetics?
A. Induction of CYP3A4, leading to decreased drug levels and potential therapeutic failure.
B. Inhibition of CYP3A4, leading to increased drug levels and potential toxicity. [CORRECT]
C. No effect, as grapefruit juice primarily affects CYP2D6.
D. Increased renal excretion of the drug, decreasing its half-life.
Correct Answer: B
Rationale: Grapefruit juice contains furanocoumarins, which irreversibly inhibit intestinal
CYP3A4 enzymes. This inhibition reduces the first-pass metabolism of drugs that are CYP3A4
substrates, leading to increased bioavailability and higher plasma levels of the drug. This can
result in toxicity. St. John's Wort, conversely, is a potent inducer.
Q4: Which of the following patients is most likely to experience an exaggerated response to a
standard dose of a highly protein-bound drug (e.g., warfarin)?
A. A 30-year-old athlete with high albumin levels.
B. An elderly patient with malnutrition and hypoalbuminemia. [CORRECT]
C. A pediatric patient with normal liver function.
D. A pregnant patient in the second trimester.
Correct Answer: B
Rationale: Drugs that are highly protein-bound (like warfarin) circulate mostly bound to
albumin; only the free (unbound) fraction is pharmacologically active. Hypoalbuminemia,
,3
common in elderly and malnourished patients, decreases the number of binding sites. This results
in a higher free fraction of the drug, potentially leading to toxicity even at standard doses.
Q5: A patient with a history of end-stage renal disease requires antibiotic therapy. The nurse
practitioner prescribes a drug eliminated primarily by the kidneys. What adjustment is necessary?
A. Increase the dose frequency to ensure adequate tissue penetration.
B. Extend the dosing interval or reduce the dose. [CORRECT]
C. Administer the drug intravenously only to bypass first-pass metabolism.
D. No adjustment is needed as long as liver function is normal.
Correct Answer: B
Rationale: Renal impairment reduces the clearance of drugs eliminated via the kidneys (e.g.,
aminoglycosides, penicillins, vancomycin). To prevent drug accumulation and toxicity, the
dosing interval should be extended (giving the drug less frequently) or the dose reduced.
Increasing the dose (A) would worsen accumulation.
Q6: The nurse practitioner is educating a patient about the "first-pass effect." Which route of
administration is subject to the highest degree of first-pass metabolism?
A. Oral [CORRECT]
B. Sublingual
C. Intravenous
D. Transdermal
Correct Answer: A
Rationale: First-pass metabolism refers to the partial inactivation of a drug by the liver before it
reaches systemic circulation. Oral administration is the route most significantly affected because
the drug is absorbed from the GI tract and travels directly to the liver via the portal vein. IV (C)
bypasses this entirely.
, 4
Q7: A drug is described as a "partial agonist" at the mu-opioid receptor. How does this differ
from a "full agonist"?
A. It produces a maximal response regardless of receptor occupancy.
B. It produces a submaximal response even when all receptors are occupied. [CORRECT]
C. It binds to the receptor but produces no effect, blocking full agonists.
D. It has a lower affinity for the receptor than a full agonist.
Correct Answer: B
Rationale: A partial agonist binds to the receptor and activates it but produces a submaximal
response (lower Emax) compared to a full agonist, even when all receptors are occupied. This
property can be useful for stabilizing a receptor system (e.g., buprenorphine in opioid use
disorder). Option C describes an antagonist.
Q8: The nurse practitioner is reviewing the concept of "Volume of Distribution" (Vd). A drug
with a high Vd (e.g., digoxin or lipophilic drugs) is likely to:
A. Remain primarily in the blood plasma.
B. Distribute widely into tissues and body fat. [CORRECT]
C. Be easily removed by dialysis.
D. Have a short half-life.
Correct Answer: B
Rationale: A high volume of distribution indicates that the drug preferentially distributes out of
the plasma and into the tissues (e.g., adipose tissue, intracellular). These drugs are often
lipophilic. They are often difficult to remove via dialysis (C) because they are not floating freely
in the blood. Drugs with high Vd typically have long half-lives.
Q9: Which medication requires a "washout period" of 5 weeks before starting an SSRI to prevent
Serotonin Syndrome?
A. Moclobemide
B. Tranylcypromine
